Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.4144
Delayed Data
As of May 27
 +0.0044 / +1.07%
Today’s Change
0.29
Today|||52-Week Range
1.50
-64.58%
Year-to-Date
No recent news for Peregrine Pharmaceuticals Inc.

Today’s Trading

Previous close0.41
Today’s open0.41
Day’s range0.41 - 0.42
Volume505,046
Average volume (3 months)1,535,739
Market cap$96.9M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)+13.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...-0.21-2.82%
CLCDCoLucid Pharmaceutic...+0.07+1.12%
CRMECardiome Pharma Corp+0.08+1.69%
OHRPOHR Pharmaceutical I...+0.03+0.97%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateJuly 11, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

Partner Offers

Search for Jobs